Psychedelic Brain · 迷幻研究文獻日報

📅 2026年6月28日(週日) 📊 13 篇文獻 Powered by PubMed + Zhipu AI

📋 今日文獻趨勢

今日共收錄 13 篇迷幻研究文獻。

今日精選 TOP Picks
📚其他值得關注的文獻
📄

Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care.

Translational psychiatry

Clinical trials investigating psychedelic compounds for depression and anxiety-related disorders are yielding promising preliminary results. Psychedel

📄

Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.

Molecular psychiatry

Major depressive disorder (MDD) and treatment-resistant depression (TRD) are prevalent and debilitating conditions. Over 50% of patients have inadequa

📄

Clinical and non-clinical use of MDMA.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

📄

The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.

Journal of psychopharmacology (Oxford, England)

With growing research on the use of psychedelics to treat mental health conditions, greater attention to the psychosocial procedures accompanying subs

📄

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Based on its in vitro profile and preliminary evidence, 4-bromo-2,5-dimethoxyphenethylamine (2C-B) may have psychoactive properties that are similar t

📄

The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.

Journal of psychopharmacology (Oxford, England)

In the past decade, interest in studying psychedelic compounds as potential therapeutic agents has resurged. These studies carefully exclude individua

📄

Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.

Journal of clinical psychopharmacology

BACKGROUND: Ibogaine has garnered interest for its potential therapeutic properties in substance use and psychiatric disorders. Unlike classic psyched

📄

A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.

The International journal on drug policy

BACKGROUND: We know little about the extent psychedelic substances are consumed therapeutically and/or discussed with medical professionals despite re

🏷️關鍵字
psychedelicpsilocybinMDMA
🏥 李政洋身心診所首頁